Relevance of plasma biomarkers to pathologies in Alzheimer’s disease, Parkinson’s disease and frontotemporal dementia

Relevance of Plasma Biomarkers to Pathologies in Alzheimer's Disease, Parkinson's Disease and Frontotemporal Dementia - Chiu et al. 2023

Relevance of Plasma Biomarkers to Pathologies in Alzheimer's Disease, Parkinson's Disease and Frontotemporal Dementia

© 2022 Chiu, Yang, Chiu, Lin, Lu and Yang

Scientific Reports - Nature

Previous
Previous

Continuous Positive Airway Pressure Reduces Plasma Neurochemical Levels in Patients with OSA: A Pilot Study

Next
Next

Associations between blood-based biomarkers of Alzheimer’s disease with cognition in motoric cognitive risk syndrome: A pilot study using plasma Aβ42 and total tau